175 related articles for article (PubMed ID: 8365810)
1. Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls.
Bitzan M; Klemt M; Steffens R; Müller-Wiefel DE
Infection; 1993; 21(3):140-5. PubMed ID: 8365810
[TBL] [Abstract][Full Text] [Related]
2. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study.
Bitzan M; Ludwig K; Klemt M; König H; Büren J; Müller-Wiefel DE
Epidemiol Infect; 1993 Apr; 110(2):183-96. PubMed ID: 8472763
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1.
Karmali MA; Petric M; Winkler M; Bielaszewska M; Brunton J; van de Kar N; Morooka T; Nair GB; Richardson SE; Arbus GS
J Clin Microbiol; 1994 Jun; 32(6):1457-63. PubMed ID: 8077389
[TBL] [Abstract][Full Text] [Related]
4. [Anti-verotoxin-neutralizing antibody in intravenous gammaglobulin preparations].
Adachi E; Yoshino K; Kimura T; Matsumoto Y; Takeda T
Kansenshogaku Zasshi; 1998 Aug; 72(8):808-12. PubMed ID: 9780583
[TBL] [Abstract][Full Text] [Related]
5. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
Kiarash A; Boyd B; Lingwood CA
J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
[TBL] [Abstract][Full Text] [Related]
6. Ability of human sera to neutralise the activity of Vero cytotoxins VT1, VT2 and variant forms of VT2.
Scotland SM; Said B; Thomas A; Rowe B
FEMS Microbiol Lett; 1994 Jan; 115(2-3):285-9. PubMed ID: 8138140
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157:H7 in mice.
Kuribayashi T; Seita T; Fukuyama M; Furuhata K; Honda M; Matsumoto M; Seguchi H; Yamamoto S
J Infect Chemother; 2006 Oct; 12(5):251-6. PubMed ID: 17109087
[TBL] [Abstract][Full Text] [Related]
8. Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.
Bielaszewska M; Clarke I; Karmali MA; Petric M
Infect Immun; 1997 Jul; 65(7):2509-16. PubMed ID: 9199412
[TBL] [Abstract][Full Text] [Related]
9. Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2.
Chart H; Law D; Rowe B; Acheson DW
J Clin Pathol; 1993 Nov; 46(11):1053-4. PubMed ID: 8254096
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli.
Karmali MA; Petric M; Bielaszewska M
J Clin Microbiol; 1999 Feb; 37(2):396-9. PubMed ID: 9889226
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
Boyd B; Tyrrell G; Maloney M; Gyles C; Brunton J; Lingwood C
J Exp Med; 1993 Jun; 177(6):1745-53. PubMed ID: 8496689
[TBL] [Abstract][Full Text] [Related]
12. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7.
Padhye VV; Zhao T; Doyle MP
J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749
[TBL] [Abstract][Full Text] [Related]
13. Protection against verocytotoxin in mice induced by liposome-coupled verocytotoxin.
Naito S; Horino A; Komiya T; Fukuda Y; Takahashi M; Ami Y; Suzaki Y; Satoh S; Gondaira F; Sugiyama J; Nakano Y; Mori M; Awai K; Nishinohara S; Komuro K; Uchida T
Int Arch Allergy Immunol; 1997 Nov; 114(3):293-7. PubMed ID: 9363912
[TBL] [Abstract][Full Text] [Related]
14. Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction.
Pollard DR; Johnson WM; Lior H; Tyler SD; Rozee KR
J Clin Microbiol; 1990 Mar; 28(3):540-5. PubMed ID: 2182671
[TBL] [Abstract][Full Text] [Related]
15. Pheno-genotyping of verotoxin 2 (VT2)-producing Escherichia coli causing haemorrhagic colitis and haemolytic uraemic syndrome by direct analysis of patients' stools.
Caprioli A; Luzzi I; Gianviti A; Russmann H; Karch H
J Med Microbiol; 1995 Nov; 43(5):348-53. PubMed ID: 7562999
[TBL] [Abstract][Full Text] [Related]
16. Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro.
Bitzan M; Richardson S; Huang C; Boyd B; Petric M; Karmali MA
Infect Immun; 1994 Aug; 62(8):3337-47. PubMed ID: 8039905
[TBL] [Abstract][Full Text] [Related]
17. Genes coding for Shiga-like toxins in bovine verotoxin-producing Escherichia coli (VTEC) strains belonging to different O:K:H serotypes.
Blanco M; Blanco J; Blanco JE; González EA; Gomes TA; Zerbini LF; Yano T; de Castro AF
Vet Microbiol; 1994 Nov; 42(2-3):105-10. PubMed ID: 7886925
[TBL] [Abstract][Full Text] [Related]
18. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
Devenish J; Gyles C; LaMarre J
Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
[TBL] [Abstract][Full Text] [Related]
19. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Bast DJ; Brunton JL; Karmali MA; Richardson SE
Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
[TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacies of bovine immune colostral antibody and each immunoglobulin class against verotoxin 2, flagellum and somatic cells of Escherichia coli O157:H7 in mice.
Seita T; Kuribayashi T; Honjo T; Yamamoto S
J Microbiol Immunol Infect; 2013 Apr; 46(2):73-9. PubMed ID: 22572001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
